Congratulation!EYESIS into the First Affiliated Hospital of Zhengzhou University

Good news, after the comprehensive evaluation of many brands by many ophthalmologists, it was finally decided to choose MDC EYESIS dry eye therapeutic instrument to settle in the Eye Center of the First Affiliated Hospital of Zhengzhou University.

The First Affiliated Hospital of Zhengzhou University was founded in September 1928 and has a history of nearly 100 years. Now it has 4 hospital districts, including Heyi Hospital, East Hospital District, North Hospital District and South Hospital District, with nearly 7000 beds. It is praised by the media as the world's largest hospital.

In addition to its large scale, advanced hospital facilities and complete equipment, the number and quality of medical equipment rank among the top in China, and it has many honors such as the National Top 100 Hospitals and Henan Double Top 10 Hospitals. In the ranking of the best hospitals in China, the First Affiliated Hospital of Zhengzhou University ranks 19 in the comprehensive ranking of the country, and the scientific research ranks 4 in the country; The national hospital natural index ranks 11th in China.

Dry eye is the most common ocular surface disease. The incidence rate in China is about 21~30%. The number of patients is large, and it is the second disease in the daily reception of ophthalmic clinics. The population of Henan Province is about 96.4 million, with a large population. The demand for dry eye diagnosis and treatment is very large.

According to the pathogenesis of dry eye, 2017 TFOS DEWS II, the consensus of dry eye treatment experts in China in 2020 and recent new relevant research have listed intense pulsed light (IPL) as an important method of dry eye comprehensive treatment. Intense pulsed light (IPL) has the characteristics of non-invasive, relatively safe, rapid action, and definite curative effect, and is increasingly widely used in clinical applications in China.

In order to build the most advanced dry eye diagnosis and treatment center in China, experts from the Ophthalmology Center of the First Affiliated Hospital of Zhengzhou University investigated several intense pulsed light products of related brands, comprehensively evaluated the product use effect, registration indications, academic level, after-sales service and other factors, and finally unanimously recognized that the MDC EYESIS dry eye therapeutic instrument is the best choice. The reasons are as follows:

1、 MDC EYESIS dry eye therapeutic instrument has been used in nearly 200 key hospitals nationwide.

2、 The remarkable effect of MDC EYESIS dry eye therapeutic instrument has been verified by tens of thousands of patients.

3、 MDC EYESIS dry eye therapeutic instrument is a dry eye therapeutic product with ophthalmic indications.

4、 MDC EYESIS dry eye therapeutic instrument is not only applicable to various types of dry eyes, but also covers dry eye patients of all ages.

EYESIS dry eye therapeutic instrument is a key technology promoted by the National Health Commission. It adopts MOPT (multiple optimal pulse technology) which has reached the international level. It is the fourth generation of strong pulse light technology following the second generation of OPT (optimal pulse technology) and the third generation of IRPL (adjustable pulse light). EYESIS can not only set different treatment parameters for patients with different indications and different skin colors, but also cover all age groups from young patients to elderly patients. Up to now, more than 300 hospitals have introduced MDC EYESIS dry eye treatment equipment.

Finally, the First Affiliated Hospital of Zhengzhou University kindly reminds that IPL is applicable to the following patient groups:

(1)Patients with meibomian gland dysfunction;

(2)Patients with styloma, chalazion and demodex blepharitis;

(3)Patients with blepharitis associated keratoconjunctivitis (BKC);

(4)Patients with ocular surface lesions related to skin diseases.